CNS004 is a novel compound that potentiates NMDA receptor currents based on glutamate concentration. This compound alters glutamate potency and exhibits no voltage-dependent effect.
For research use only. We do not sell to patients.
Name | CNS004 |
---|---|
Iupac Chemical Name | 4-fluoro-N-(2-(pyridin-3-yl)piperidine-1-carbonothioyl)benzamide |
Synonyms | CNS004 ; CNS-004 ; CNS 004 |
Molecular Formula | C18H18FN3OS |
Molecular Weight | 343.42 |
Smile | O=C(NC(N1C(C2=CC=CN=C2)CCCC1)=S)C3=CC=C(F)C=C3 |
InChiKey | OPBIMMOKSSEPPP-UHFFFAOYSA-N |
InChi | InChI=1S/C18H18FN3OS/c19-15-8-6-13(7-9-15)17(23)21-18(24)22-11-2-1-5-16(22)14-4-3-10-20-12-14/h3-4,6-10,12,16H,1-2,5,11H2,(H,21,23,24) |
CAS Number | 695205-24-4 |
Related CAS | 695205-24-4 |
Packaging | Price | Availability | Purity | Shipping Time |
---|---|---|---|---|
Bulk | Enquiry | Enquiry | Enquiry |
Formulation | Off-white solid |
---|---|
Purity | ≧98.0% |
Storage | Dry, dark and at 0 - 4℃ for short term (days to weeks) or -20℃ for long term (months to years). |
Solubility | Soluble in DMSO |
Handling | Refer to MSDS |
Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
HS Code | 2934200090 |
Targets | |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |